Clinical trial
Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for…
NCT00110110 · The Hospital for Sick Children, Other · Active, not recruiting
Key facts
| NCT number | NCT00110110 |
|---|---|
| Title | Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma |
| Official title | Multicenter Phase II Study for International Intraocular Retinoblastoma Classification Groups B, C & D Tumors Treated With Carboplatin-Etoposide-Vincristine-Cyclosporine-Focal Therapy Multimodality Protocol (OCRN Multicenter RB 2003) |
| Lead sponsor | The Hospital for Sick Children, Other |
| Collaborators | Terry Fox Foundation |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Retinoblastoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, Carboplatin, Cyclosporine, Etoposide, vincristine sulfate, cryosurgery, laser therapy |
| Enrollment | 71 |
| Start date | Jun 1, 2004 |
| Primary completion | Apr 20, 2016 |
| Completion | Dec 31, 2024 |
| First posted | May 4, 2005 |
| Last update posted | Apr 17, 2024 |
| Countries | Canada, Chile, India, Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: